or Try an Advanced Search...

    Refractory Acute Myeloid Leukemia Stocks List

    Symbol Grade Name % Change
    XBIO C Xenetic Biosciences, Inc. 2.30
    MBRX D Moleculin Biotech, Inc. -3.53
    CRBU F Caribou Biosciences, Inc. 2.02
    SYRS F Syros Pharmaceuticals, Inc. 12.77
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Acute Myeloid Leukemia Biopharmaceutical Biotechnology Cancer Leukemia Medicine Treatment Of Relapsed Or Refractory Acute Myeloid Leukemia Acute Leukemia Anemia Antineoplastic Drugs Blastoma Breakthrough Therapy CD19 Cancer Immunotherapy Cell Biology Cell Therapy Chemotherapy Chimeric Antigen Receptor T Cell Chronic Kidney Disease Clinical Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Refractory Acute Myeloid Leukemia stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 1.47
    NXTE D AXS Green Alpha ETF 1.17
    WDNA F WisdomTree BioRevolution Fund 0.52
    GNOM F Global X Genomics & Biotechnology ETF 0.33
    IWC B iShares Microcap ETF 0.04
    View all Refractory Acute Myeloid Leukemia ETFs...
    Compare ETFs
    Compare CNCR to IWC Compare NXTE to GNOM Compare NXTE to WDNA

        Refractory Acute Myeloid Leukemia Stocks Recent News

        Date Stock Title
        Nov 21 XBIO Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
        Nov 20 CRBU Caribou Biosciences to Participate in Upcoming Investor Conferences
        Related Industries: Biotechnology
        Related Stock Lists: Acute Myeloid Leukemia Biopharmaceutical Biotechnology Cancer Leukemia Medicine Treatment Of Relapsed Or Refractory Acute Myeloid Leukemia Acute Leukemia Anemia Antineoplastic Drugs Blastoma Breakthrough Therapy CD19 Cancer Immunotherapy Cell Biology Cell Therapy Chemotherapy Chimeric Antigen Receptor T Cell Chronic Kidney Disease Clinical Medicine
        Refractory Acute Myeloid Leukemia

        Refractory Acute Myeloid Leukemia (AML) is a type of cancer of the blood and bone marrow that is resistant to standard treatments. It is a rare and aggressive form of leukemia that is difficult to treat and has a poor prognosis. Symptoms of AML include fatigue, fever, weight loss, and anemia. Treatment options for refractory AML include chemotherapy, stem cell transplant, and targeted therapies.

        Browse All Tags